Sthaler created a unique biometric, identity and payment service originally designed for music festivals called Fingopay. It has caught the attention of retail sectors in need of fast, safe and accurate customer experiences. Now, through its global partners we are aiming to achieve scale and reach.
Having grown from a tiny market stall to a critically acclaimed restaurant, Monty’s Deli are aiming to expand their offering across a number of new market sites in London.
Awesome Merchandise is one of the UK's fastest growing print & merch companies. So far they've made more than 65 million items for 70,000 customers worldwide, and have been profitable every year. In 2018 they plan to introduce European and US websites, as well as a new factory in Austin, TX, USA.
Producing over two million Smoothie Kits for our customers so far, PACK’D is a natural nutrition brand on a mission to fuel potential. Grown from a Prince’s Trust market stall to one of the UK’s ‘Top 50 Startups’, the company now has over 1500 product listings including Sainsburys and Ocado.
BABB is building a decentralised banking platform and aims to provide peer-to-peer banking services designed for the global microeconomy. With $18 million backing for software development, it is now raising funds to meet the capital requirement to become a licensed bank in the UK and/or EU.
Flair Atelier creates fully customised garments via an online platform. Thanks to a combination of beautiful design, intuitive technology and meticulous craftsmanship, starting with one of the designs, the user can create the perfect dress without the cost or hassle of traditional tailoring.
Glint are reintroducing gold as money into the global payments system. Their Glint app and Mastercard allows users to buy, store & spend physical gold alongside national currencies. Launched in February, they are now raising to expand globally through licenses & distribution partnerships.
NowMe is an end-to-end digital platform for the fast growing $99.8b aesthetic medical treatment market. We help users learn all about the treatment they seek, book an instant consultation with experienced medical practitioners and facilitate finance. We aim to achieve UK market leadership by 2021.
Aiming to resolve the problem of DNA data breach & exploitation by providing individual users with a technology to sequence, store, manage & commercialise their genomic data. We will help users to protect the most valuable piece of private information they will ever possess: their DNA data.
Investing in start-ups and early stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Crowdcube is targeted exclusively at investors who are sufficiently sophisticated to understand these risks and make their own investment decisions. You will only be able to invest via Crowdcube once you are registered as sufficiently sophisticated.
Please click here to read the full risk warning. This page is approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority. Pitches for investment are not offers to the public and investments can only be made by members of crowdcube.com on the basis of information provided in the pitches by the companies concerned. Crowdcube takes no responsibility for this information or for any recommendations or opinions made by the companies.
The availability of any tax relief, including EIS and SEIS, depends on the individual circumstances of each investor and of the company concerned, and may be subject to change in the future. If you are in any doubt about the availability of any tax reliefs, or the tax treatment of your investment, you should obtain independent tax advice before proceeding with your investment.